Jie Wu

ORCID: 0000-0002-6039-9119 · 15 papers in corpus
other 2026
Frontiers in oncology ·doi:10.3389/fonc.2026.1674171

OBJECTIVE: To assess the safety and efficacy of percutaneous intrauterine hydrodissection as a protective technique during microwave ablation (MWA) of uterine fibroids adjacent to the endometrium. MATERIALS AND METHODS: A retrospective ana…

meta-analysis 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02008-x

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by ovulatory dysfunction and hormonal imbalance, often leading to infertility. Cangfu Daotan Decoction (CFDTT, Atractylodis Rhizoma, Cyperi Rhizoma, P…

observational 2025
Frontiers in public health ·doi:10.3389/fpubh.2025.1513358

BACKGROUND: Visceral fat accumulation and dyslipidaemia are associated with infertility symptoms. The cardiometabolic index (CMI) is a comprehensive quantitative measure of central obesity and dyslipidaemia. However, the link between the fe…

observational 2025
Discover oncology ·doi:10.1007/s12672-025-02272-1

BACKGROUND: The clinical prognostic factors for ovarian clear cell carcinoma (OCCC) are limited, and we aim to construct a model to predict the survival of OCCC patients. METHODS: Data were extracted from the SEER database for patients dia…

other 2025
Journal of chemical information and modeling ·doi:10.1021/acs.jcim.5c00204

The human cytochrome P450 19A1 (CYP19A1, aromatase) is a heme-containing protein catalyzing the final steps of the biosynthesis of the steroid hormone 17β-estradiol. It is a key target for the treatment of sex-hormone-related disorders due …

lab-animal 2025
BMC microbiology ·doi:10.1186/s12866-025-04097-y

BACKGROUND: Premature ovarian insufficiency (POI) is a condition identified by the decline in ovarian function before the age of 40. The treatment of POI patients deserves in-depth research. This study aimed to explore the impacts of probio…

lab-animal 2024
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox13080911

Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before the age of 40 years. The global prevalence of POI is 3.5%. To date, genetic factors account for 23.5% of the etiology of POI. Herein, a previously …

case-report 2023
British journal of cancer ·doi:10.1038/s41416-023-02239-5

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a challenging disease due to its intrinsic chemoresistance. Immunotherapy is an emerging treatment option but currently impeded by insufficient understanding of OCCC immunophenotypes and th…

lab-animal 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.854345

BACKGROUND: Endometriosis (EMS) is a relapsing and estrogen-dependent disease. For endometriosis such as deep endometriosis and ovarian endometrioid cysts, surgery is the most effective treatment. Long-term follow-up showed that the recurre…

lab-animal 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.683552

BACKGROUND: Endometriosis (EMS) is an estrogen-dependent disease, which easily recurs after operation. Gonadotropin-releasing hormone agonist (GnRH-a), an estrogen-inhibiting drug, can effectively inhibit the secretion of gonadotropin by pi…

lab-animal 2021
OncoTargets and therapy ·doi:10.2147/ott.s269589

BACKGROUND: Cancer cells could show the characteristics of cancer stem cells (CSCs) through epithelial-mesenchymal transition (EMT). EZH2 was associated with EMT. Ultrasound-targeted microbubble destruction (UTMD) could enhance gene transfe…

other 2020
Medicine ·doi:10.1097/md.0000000000019044

INTRODUCTION: The purpose of this study is to evaluate the efficacy and safety of acupuncture on relieving abdominal pain and distension in acute pancreatitis. METHODS AND ANALYSIS: We will electronically search PubMed, MEDLINE, Embase, We…

rct 2014
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/msm.891353

BACKGROUND: The aim of this study was to investigate clinical efficacy and safety of Remifemin on peri-menopausal symptoms in endometriosis patients with a post-operative GnRH-a therapy. MATERIAL AND METHODS: We treated 116 women who had e…

lab-animal 2009
Endocrinology ·doi:10.1210/en.2009-0071

Diethylstilbestrol (DES) is a nonsteroidal estrogen that induces developmental anomalies of the female reproductive tract. The homeobox gene HOXA10 controls uterine organogenesis, and its expression is altered after in utero DES exposure. W…

2007
·doi:10.1016/j.fertnstert.2007.07.721